As in the case of neurodegenerative tauopathies, a detailed characterization of MAPT transcription and translation as well as the biochemical characterization of TAU protein including its modification, cellular distribution and interacting proteins, is now necessary in the studies linking TAU to cancer. The gene discussed is MAPT; the disease is cancer.